Sharps Technology Inc. financial data

Symbol
STSS, STSSW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
105 Maxess Road, Ste. 124, Melville, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 119 % -39.4%
Quick Ratio 54.8 % +97.8%
Debt-to-equity 50 % +71.3%
Return On Equity -110 % -45.1%
Return On Assets -73.6 % -24.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.8M shares -88.2%
Common Stock, Shares, Outstanding 1.69M shares -88.9%
Entity Public Float 7.62M USD +22.8%
Common Stock, Value, Issued 170 USD -88.9%
Weighted Average Number of Shares Outstanding, Basic 1.33M shares +148%
Weighted Average Number of Shares Outstanding, Diluted 1.33M shares +148%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.35M USD -12.8%
General and Administrative Expense 7.35M USD -13.3%
Operating Income (Loss) -8.7M USD +13.2%
Nonoperating Income (Expense) 330K USD -1.75%
Net Income (Loss) Attributable to Parent -7.87M USD -3.71%
Earnings Per Share, Basic 1.57 USD/shares +66.3%
Earnings Per Share, Diluted 1.57 USD/shares +66.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.47M USD -55.5%
Inventory, Net 2.02M USD +56.9%
Assets, Current 4.65M USD -32.9%
Property, Plant and Equipment, Net 6.23M USD -9.83%
Intangible Assets, Net (Excluding Goodwill) 40.2K USD -23.8%
Other Assets, Noncurrent 366K USD -30.5%
Assets 11.3M USD -21.7%
Accounts Payable, Current 946K USD
Liabilities, Current 4.59M USD +28%
Deferred Income Tax Liabilities, Net 162K USD
Liabilities 4.75M USD +25.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 483K USD +75.1%
Retained Earnings (Accumulated Deficit) -29.9M USD -35.7%
Stockholders' Equity Attributable to Parent 6.51M USD -38.6%
Liabilities and Equity 11.3M USD -21.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.89M USD +8.4%
Net Cash Provided by (Used in) Financing Activities 3.24M USD +9865%
Net Cash Provided by (Used in) Investing Activities -2.85K USD +98.3%
Common Stock, Shares Authorized 500M shares +400%
Common Stock, Shares, Issued 1.69M shares -88.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.85M USD -270%
Deferred Tax Assets, Valuation Allowance 6.47M USD +23.5%
Deferred Tax Assets, Gross 5.05M USD +71.9%
Depreciation 190K USD -10.4%
Payments to Acquire Property, Plant, and Equipment 163K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.66M USD -7.6%
Property, Plant and Equipment, Gross 8.22M USD -0.17%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 35.9M USD +11%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets 5.29K USD +32.9%
Share-based Payment Arrangement, Expense 116K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%